Amedisys, Inc. (NASDAQ:AMED) Shares Bought by Twin Securities Inc.

Twin Securities Inc. lifted its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 143.7% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 29,105 shares of the health services provider’s stock after purchasing an additional 17,160 shares during the period. Amedisys comprises approximately 1.5% of Twin Securities Inc.’s portfolio, making the stock its 11th largest holding. Twin Securities Inc.’s holdings in Amedisys were worth $2,642,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Trexquant Investment LP lifted its stake in Amedisys by 1,317.8% in the fourth quarter. Trexquant Investment LP now owns 87,719 shares of the health services provider’s stock valued at $7,964,000 after buying an additional 81,532 shares during the last quarter. ABC Arbitrage SA purchased a new stake in shares of Amedisys during the fourth quarter worth approximately $2,522,000. Schonfeld Strategic Advisors LLC raised its stake in shares of Amedisys by 17.5% during the fourth quarter. Schonfeld Strategic Advisors LLC now owns 4,500 shares of the health services provider’s stock worth $409,000 after purchasing an additional 671 shares during the last quarter. Empowered Funds LLC purchased a new stake in shares of Amedisys during the fourth quarter worth approximately $318,000. Finally, KLP Kapitalforvaltning AS purchased a new stake in shares of Amedisys during the fourth quarter worth approximately $590,000. 94.36% of the stock is owned by institutional investors and hedge funds.

Amedisys Stock Up 1.0%

Amedisys stock opened at $94.62 on Friday. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.19 and a current ratio of 1.19. The firm has a market capitalization of $3.11 billion, a price-to-earnings ratio of 37.55, a price-to-earnings-growth ratio of 1.78 and a beta of 0.96. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The stock’s fifty day moving average is $93.22 and its two-hundred day moving average is $91.63.

Amedisys (NASDAQ:AMED) last posted its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share for the quarter, beating the consensus estimate of $1.13 by $0.12. The company had revenue of $594.78 million for the quarter, compared to analyst estimates of $597.43 million. Amedisys had a return on equity of 12.20% and a net margin of 3.57%. Amedisys’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.03 earnings per share. Analysts predict that Amedisys, Inc. will post 4.4 EPS for the current fiscal year.

Analyst Ratings Changes

AMED has been the subject of several analyst reports. Royal Bank of Canada restated an “outperform” rating and set a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th. Stephens reiterated an “equal weight” rating and issued a $101.00 price objective on shares of Amedisys in a research report on Tuesday, March 4th. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $100.75.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.